<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>56(9)</volume><submitter>Marinelli C</submitter><pubmed_abstract>&lt;h4>Background/goal&lt;/h4>Ulcerative colitis (UC) is characterized by chronic inflammation and progressive course, with potential extraintestinal complications including cardiovascular mortality. Serum proprotein convertase subtilisin/kexin type 9 (PCSK9) levels have been recently recognized as biomarkers of low-grade inflammation and cardiovascular disease. The aim of our study was to evaluate PCSK9 levels in patients with UC and different degrees of disease activity.&lt;h4>Methods&lt;/h4>We prospectively recruited consecutive patients with UC attending our center at the University Hospital of Padua. Demographics, clinical characteristics, and biochemical data, including PCSK9, high sensitivity C-reactive protein, and fecal calprotectin, were recorded. Moreover, endoscopic procedures were perform</pubmed_abstract><journal>Journal of clinical gastroenterology</journal><pagination>787-793</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9988229</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study.</pubmed_title><pmcid>PMC9988229</pmcid><pubmed_authors>Casadei C</pubmed_authors><pubmed_authors>Ferri N</pubmed_authors><pubmed_authors>Gubbiotti A</pubmed_authors><pubmed_authors>Barberio B</pubmed_authors><pubmed_authors>Marinelli C</pubmed_authors><pubmed_authors>Marin R</pubmed_authors><pubmed_authors>D'Inca R</pubmed_authors><pubmed_authors>Massimi D</pubmed_authors><pubmed_authors>Zingone F</pubmed_authors><pubmed_authors>Savarino E</pubmed_authors><pubmed_authors>Lupo MG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study.</name><description>&lt;h4>Background/goal&lt;/h4>Ulcerative colitis (UC) is characterized by chronic inflammation and progressive course, with potential extraintestinal complications including cardiovascular mortality. Serum proprotein convertase subtilisin/kexin type 9 (PCSK9) levels have been recently recognized as biomarkers of low-grade inflammation and cardiovascular disease. The aim of our study was to evaluate PCSK9 levels in patients with UC and different degrees of disease activity.&lt;h4>Methods&lt;/h4>We prospectively recruited consecutive patients with UC attending our center at the University Hospital of Padua. Demographics, clinical characteristics, and biochemical data, including PCSK9, high sensitivity C-reactive protein, and fecal calprotectin, were recorded. Moreover, endoscopic procedures were perform</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-21T19:43:18.258Z</modification><creation>2025-02-19T02:21:57.95Z</creation></dates><accession>S-EPMC9988229</accession><cross_references><pubmed>34560758</pubmed><doi>10.1097/MCG.0000000000001607</doi></cross_references></HashMap>